Search Results - "Tissue Array Analysis - methods"
-
1
Simultaneous epitope and transcriptome measurement in single cells
ISSN: 1548-7091, 1548-7105, 1548-7105Published: New York Nature Publishing Group US 01.09.2017Published in Nature methods (01.09.2017)“…Using established high-throughput single-cell RNA-seq platforms, CITE-seq combines highly multiplexed, antibody-based protein marker quantification with…”
Get full text
Journal Article -
2
Automated Gleason grading of prostate cancer tissue microarrays via deep learning
ISSN: 2045-2322, 2045-2322Published: London Nature Publishing Group UK 13.08.2018Published in Scientific reports (13.08.2018)“…The Gleason grading system remains the most powerful prognostic predictor for patients with prostate cancer since the 1960s. Its application requires…”
Get full text
Journal Article -
3
Data-analysis strategies for image-based cell profiling
ISSN: 1548-7091, 1548-7105, 1548-7105Published: New York Nature Publishing Group US 01.09.2017Published in Nature methods (01.09.2017)“…This Review covers the steps required to create high-quality image-based profiles from high-throughput microscopy images. Image-based cell profiling is a…”
Get full text
Journal Article -
4
histoCAT: analysis of cell phenotypes and interactions in multiplex image cytometry data
ISSN: 1548-7091, 1548-7105, 1548-7105Published: New York Nature Publishing Group US 01.09.2017Published in Nature methods (01.09.2017)“…The histology topography cytometry analysis toolbox (histoCAT) enables quantitative analysis and exploration of highly multiplexed imaging data for better…”
Get full text
Journal Article -
5
Probing the binding specificities of human Siglecs by cell-based glycan arrays
ISSN: 1091-6490, 1091-6490Published: United States 27.04.2021Published in Proceedings of the National Academy of Sciences - PNAS (27.04.2021)“…Siglecs are a family of sialic acid-binding receptors expressed by cells of the immune system and a few other cell types capable of modulating immune cell…”
Get more information
Journal Article -
6
Microfluidic blood–brain barrier model provides in vivo‐like barrier properties for drug permeability screening
ISSN: 0006-3592, 1097-0290Published: United States Wiley Subscription Services, Inc 01.01.2017Published in Biotechnology and bioengineering (01.01.2017)“…Efficient delivery of therapeutics across the neuroprotective blood–brain barrier (BBB) remains a formidable challenge for central nervous system drug…”
Get full text
Journal Article -
7
Multi-tissue interactions in an integrated three-tissue organ-on-a-chip platform
ISSN: 2045-2322, 2045-2322Published: London Nature Publishing Group UK 18.08.2017Published in Scientific reports (18.08.2017)“…Many drugs have progressed through preclinical and clinical trials and have been available – for years in some cases – before being recalled by the FDA for…”
Get full text
Journal Article -
8
A vascularized and perfused organ-on-a-chip platform for large-scale drug screening applications
ISSN: 1473-0189, 1473-0189Published: England 31.01.2017Published in Lab on a chip (31.01.2017)“…There is a growing awareness that complex 3-dimensional (3D) organs are not well represented by monolayers of a single cell type - the standard format for many…”
Get more information
Journal Article -
9
A lung/liver-on-a-chip platform for acute and chronic toxicity studies
ISSN: 1473-0189, 1473-0189Published: England 04.12.2018Published in Lab on a chip (04.12.2018)“…The merging of three-dimensional in vitro models with multi-organ-on-a-chip (MOC) technology has taken in vitro assessment of chemicals to an unprecedented…”
Get more information
Journal Article -
10
Claudin-18 expression in oesophagogastric adenocarcinomas: a tissue microarray study of 523 molecularly profiled cases
ISSN: 0007-0920, 1532-1827, 1532-1827Published: London Nature Publishing Group UK 30.07.2019Published in British journal of cancer (30.07.2019)“…Background Claudin-18 (CLDN18) is a highly specific tight junction protein of the gastric mucosa. An isoform of CLDN18, the Claudin 18.2, has recently emerged…”
Get full text
Journal Article -
11
A reductionist metastasis-on-a-chip platform for in vitro tumor progression modeling and drug screening
ISSN: 0006-3592, 1097-0290Published: United States Blackwell Publishing Ltd 01.09.2016Published in Biotechnology and bioengineering (01.09.2016)“…Current animal and 2‐D cell culture models employed in metastasis research and drug discovery remain poor mimics of human cancer physiology. Here we describe a…”
Get full text
Journal Article -
12
3D niche microarrays for systems-level analyses of cell fate
ISSN: 2041-1723, 2041-1723Published: London Nature Publishing Group UK 14.07.2014Published in Nature communications (14.07.2014)“…The behaviour of mammalian cells in a tissue is governed by the three-dimensional (3D) microenvironment and involves a dynamic interplay between biochemical…”
Get full text
Journal Article -
13
Statistical characterization and classification of colon microarray gene expression data using multiple machine learning paradigms
ISSN: 0169-2607, 1872-7565, 1872-7565Published: Ireland Elsevier B.V 01.07.2019Published in Computer methods and programs in biomedicine (01.07.2019)“…•Identification of high risk differential gene expression using statistical tests.•Development of a machine learning strategy for predicting the cancerous…”
Get full text
Journal Article -
14
Pre-arrayed Pan-AAV Peptide Display Libraries for Rapid Single-Round Screening
ISSN: 1525-0024, 1525-0024Published: United States 08.04.2020Published in Molecular therapy (08.04.2020)“…Display of short peptides on the surface of adeno-associated viruses (AAVs) is a powerful technology for the generation of gene therapy vectors with altered…”
Get more information
Journal Article -
15
Transcriptomic analysis of probable asymptomatic and symptomatic alzheimer brains
ISSN: 0889-1591, 1090-2139, 1090-2139Published: Netherlands Elsevier Inc 01.08.2019Published in Brain, behavior, and immunity (01.08.2019)“…•Asymptomatic AD subjects show increased transcriptomic activity in frontal cortex.•Disruption in brain energy pathway detected in Asymptomatic AD…”
Get full text
Journal Article -
16
Centromere and kinetochore gene misexpression predicts cancer patient survival and response to radiotherapy and chemotherapy
ISSN: 2041-1723, 2041-1723Published: London Nature Publishing Group UK 31.08.2016Published in Nature communications (31.08.2016)“…Chromosomal instability (CIN) is a hallmark of cancer that contributes to tumour heterogeneity and other malignant properties. Aberrant centromere and…”
Get full text
Journal Article -
17
Pooled CRISPR screens with imaging on microraft arrays reveals stress granule-regulatory factors
ISSN: 1548-7091, 1548-7105, 1548-7105Published: New York Nature Publishing Group US 01.06.2020Published in Nature methods (01.06.2020)“…Genetic screens using pooled CRISPR-based approaches are scalable and inexpensive, but restricted to standard readouts, including survival, proliferation and…”
Get full text
Journal Article -
18
Human stomach-on-a-chip with luminal flow and peristaltic-like motility
ISSN: 1473-0189, 1473-0189Published: England 09.10.2018Published in Lab on a chip (09.10.2018)“…Current in vitro approaches and animal models have critical limitations for modeling human gastrointestinal diseases because they may not properly represent…”
Get more information
Journal Article -
19
Mapping of truncated O-glycans in cancers of epithelial and non-epithelial origin
ISSN: 0007-0920, 1532-1827, 1532-1827Published: London Nature Publishing Group UK 26.10.2021Published in British journal of cancer (26.10.2021)“…Background Novel immunotherapies targeting cancer-associated truncated O-glycans Tn (GalNAcα-Ser/Thr) and STn (Neu5Acα2–6GalNacα-Ser/Thr) are promising…”
Get full text
Journal Article -
20
Concordance study of PD-L1 expression in primary and metastatic bladder carcinomas: comparison of four commonly used antibodies and RNA expression
ISSN: 0893-3952, 1530-0285, 1530-0285Published: New York Nature Publishing Group US 01.04.2018Published in Modern pathology (01.04.2018)“…Therapy with anti-PD-L1 immune check-point inhibitors is approved for several cancers, including advanced urothelial carcinomas. PD-L1 prevalence estimates…”
Get full text
Journal Article